Effects of glycyrrhizinic acid on neuromotor function in leptin-resistant mice

Introduction. Among all types, type 2 diabetes mellitus (T2DM) shows the most rapidly growing prevalence, and has the greatest number of complications including peripheral polyneuropathy, which is aggravated with age. In view of this, the search for effective agents for the correction of T2DM-associ...

Full description

Saved in:
Bibliographic Details
Main Authors: T. M. Matuzok, V. A. Prikhodko, S. M. Napalkova, O. V. Buyuklinskaya, S. V. Okovityi
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2023-09-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/2141
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849696276590886912
author T. M. Matuzok
V. A. Prikhodko
S. M. Napalkova
O. V. Buyuklinskaya
S. V. Okovityi
author_facet T. M. Matuzok
V. A. Prikhodko
S. M. Napalkova
O. V. Buyuklinskaya
S. V. Okovityi
author_sort T. M. Matuzok
collection DOAJ
description Introduction. Among all types, type 2 diabetes mellitus (T2DM) shows the most rapidly growing prevalence, and has the greatest number of complications including peripheral polyneuropathy, which is aggravated with age. In view of this, the search for effective agents for the correction of T2DM-associated polyneuropathy is highly relevant.Aim. To study the effects of course administration (1 month) of glycyrrhizinic acid (GA) (20 mg/kg/d) on neuromotor function in female leptin-resistant diabetic db/db mice of different ages using stimulation electroneuromyography (ENMG).Materials and methods. The study was conducted in female C57Bl/Ks-db+/+m (db/db) mice weighing 40–48 g, aged 2 months (n = 15) or 6 months (n = 10) that were randomized into 4 groups: 1) control (C) (2 months (C2): n = 7; 6 months (C6): n = 5); 2) GA-treated (20 mg/kg/d p/o × 1 month) (2 months (GA2): n = 8; 6 months (GA6): n = 5). Following 1 month of treatment, an ENMG study of m. gastrocnemius and m. biceps brachii electrical activity was conducted using the following protocols: single stimulus presentation, electrical stimulation-induced fatigue, and repetitive stimulation. Additionally, nerve conduction velocity (NCV) was measured for n. ischiadicus.Results and discussion. In the GA2 group, compound muscle action potential (CMAP) peak amplitude and area in the biceps were 37.4 % (p < 0.05) and 44.5 % (p < 0.01) lower than respective control values, which may be related to possible hypokalemia induced by long-term GA use, including that resulting from 11β-hydroxysteroid dehydrogenase-2 inhibition. The relatively smaller reduction of the same parameters observed in the GA6 group may be explained by lower basal enzyme activity in aged animals. CMAP durations in the biceps were 21.7 % lower in the C6 group vs. C2 (p < 0.05), while threshold current values were 48.4 and 50.4 % higher in both GA2 and C6 groups vs. C2 (p < 0.01 for both). The decrease in CMAP duration and increase in threshold currents possibly reflects age-associated changes including muscle fiber and motor unit loss.Conclusion. GA (20 mg/kg/day × 1 months) in young adult (2 months) female leptin-resistant mice reduced single stimulus-induced CMAP amplitude and area in the biceps muscle. The compound had no effect on sciatic NCV and post-ESIF recovery rates of the gastrocnemius and biceps in both 2 month- and 6 month-old mice.
format Article
id doaj-art-1fe487cec310453fa2d2b7da0a05df4a
institution DOAJ
issn 2305-2066
2658-5049
language Russian
publishDate 2023-09-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj-art-1fe487cec310453fa2d2b7da0a05df4a2025-08-20T03:19:31ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492023-09-010010.33380/2305-2066-2025-14-3-20301373Effects of glycyrrhizinic acid on neuromotor function in leptin-resistant miceT. M. Matuzok0V. A. Prikhodko1S. M. Napalkova2O. V. Buyuklinskaya3S. V. Okovityi4Saint-Petersburg State Chemical and Pharmaceutical University; N. P. Behtereva Institute of the Human Brain of the Russian Academy of SciencesSaint-Petersburg State Chemical and Pharmaceutical University; N. P. Behtereva Institute of the Human Brain of the Russian Academy of SciencesSaint-Petersburg State Chemical and Pharmaceutical UniversitySaint-Petersburg State Chemical and Pharmaceutical UniversitySaint-Petersburg State Chemical and Pharmaceutical University; N. P. Behtereva Institute of the Human Brain of the Russian Academy of SciencesIntroduction. Among all types, type 2 diabetes mellitus (T2DM) shows the most rapidly growing prevalence, and has the greatest number of complications including peripheral polyneuropathy, which is aggravated with age. In view of this, the search for effective agents for the correction of T2DM-associated polyneuropathy is highly relevant.Aim. To study the effects of course administration (1 month) of glycyrrhizinic acid (GA) (20 mg/kg/d) on neuromotor function in female leptin-resistant diabetic db/db mice of different ages using stimulation electroneuromyography (ENMG).Materials and methods. The study was conducted in female C57Bl/Ks-db+/+m (db/db) mice weighing 40–48 g, aged 2 months (n = 15) or 6 months (n = 10) that were randomized into 4 groups: 1) control (C) (2 months (C2): n = 7; 6 months (C6): n = 5); 2) GA-treated (20 mg/kg/d p/o × 1 month) (2 months (GA2): n = 8; 6 months (GA6): n = 5). Following 1 month of treatment, an ENMG study of m. gastrocnemius and m. biceps brachii electrical activity was conducted using the following protocols: single stimulus presentation, electrical stimulation-induced fatigue, and repetitive stimulation. Additionally, nerve conduction velocity (NCV) was measured for n. ischiadicus.Results and discussion. In the GA2 group, compound muscle action potential (CMAP) peak amplitude and area in the biceps were 37.4 % (p < 0.05) and 44.5 % (p < 0.01) lower than respective control values, which may be related to possible hypokalemia induced by long-term GA use, including that resulting from 11β-hydroxysteroid dehydrogenase-2 inhibition. The relatively smaller reduction of the same parameters observed in the GA6 group may be explained by lower basal enzyme activity in aged animals. CMAP durations in the biceps were 21.7 % lower in the C6 group vs. C2 (p < 0.05), while threshold current values were 48.4 and 50.4 % higher in both GA2 and C6 groups vs. C2 (p < 0.01 for both). The decrease in CMAP duration and increase in threshold currents possibly reflects age-associated changes including muscle fiber and motor unit loss.Conclusion. GA (20 mg/kg/day × 1 months) in young adult (2 months) female leptin-resistant mice reduced single stimulus-induced CMAP amplitude and area in the biceps muscle. The compound had no effect on sciatic NCV and post-ESIF recovery rates of the gastrocnemius and biceps in both 2 month- and 6 month-old mice.https://www.pharmjournal.ru/jour/article/view/2141glycyrrhizinic acidtype 2 diabetes mellitusnon-alcoholic fatty liver diseaseaginghepatoprotectorselectroneuromyography
spellingShingle T. M. Matuzok
V. A. Prikhodko
S. M. Napalkova
O. V. Buyuklinskaya
S. V. Okovityi
Effects of glycyrrhizinic acid on neuromotor function in leptin-resistant mice
Разработка и регистрация лекарственных средств
glycyrrhizinic acid
type 2 diabetes mellitus
non-alcoholic fatty liver disease
aging
hepatoprotectors
electroneuromyography
title Effects of glycyrrhizinic acid on neuromotor function in leptin-resistant mice
title_full Effects of glycyrrhizinic acid on neuromotor function in leptin-resistant mice
title_fullStr Effects of glycyrrhizinic acid on neuromotor function in leptin-resistant mice
title_full_unstemmed Effects of glycyrrhizinic acid on neuromotor function in leptin-resistant mice
title_short Effects of glycyrrhizinic acid on neuromotor function in leptin-resistant mice
title_sort effects of glycyrrhizinic acid on neuromotor function in leptin resistant mice
topic glycyrrhizinic acid
type 2 diabetes mellitus
non-alcoholic fatty liver disease
aging
hepatoprotectors
electroneuromyography
url https://www.pharmjournal.ru/jour/article/view/2141
work_keys_str_mv AT tmmatuzok effectsofglycyrrhizinicacidonneuromotorfunctioninleptinresistantmice
AT vaprikhodko effectsofglycyrrhizinicacidonneuromotorfunctioninleptinresistantmice
AT smnapalkova effectsofglycyrrhizinicacidonneuromotorfunctioninleptinresistantmice
AT ovbuyuklinskaya effectsofglycyrrhizinicacidonneuromotorfunctioninleptinresistantmice
AT svokovityi effectsofglycyrrhizinicacidonneuromotorfunctioninleptinresistantmice